The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a
carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized …

New Delhi metallo-β-lactmase-1 (NDM-1) has recently emerged as a global threat because
of its ability to confer resistance to almost all clinically used β-lactam antibiotics, its presence …

The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease.
Recently, a readily transferable antibiotic resistance factor called the New Delhi metallo-β …

Background The emergence of carbapenemase producing bacteria, especially New Delhi
metallo-β-lactamase (NDM-1) and its variants, worldwide, has raised amajor public health …

New Delhi metallo-β-lactamases (NDMs), the recent additions to metallo-β-lactamases
(MBLs), pose a serious public health threat due to its highly efficient hydrolysis of β-lactam …

The New Delhi Metallo-β-lactamase (NDM-1) gene makes multiple pathogenic
microorganisms resistant to all known β-lactam antibiotics. The rapid emergence of NDM-1 …

The rapid emergence of carbapenemase producing Gram-negative bacterial strains exhibit
broad-spectrum β-lactam resistance, especially New Delhi metallo-β-lactamase (NDM-1). It …

The New Delhi Metallo-β-lactamase (NDM-1) was first reported in 2009 in a Swedish
patient. A recent study reported that Klebsiella pneumonia NDM-1 positive strain or …

New Delhi metallo-β-lactamase-1 exhibits a broad substrate profile for hydrolysis of the
penicillin, cephalosporin and 'last resort'carbapenems, and thus confers bacterial resistance …

Abstract Bacteria carrying New Delhi metallo-β-lactamase-1 (New Delhi metallo-β-
lactamase, NDM-1) resistance gene is a new type of “superbug”, which can hydrolyze …